tiprankstipranks
ImmunityBio (IBRX) Stock Soaring on Plans to Bridge Gaps in Cancer Treatments
PremiumMarket NewsImmunityBio (IBRX) Stock Soaring on Plans to Bridge Gaps in Cancer Treatments
25d ago
Unusually active option classes on open October 28th
Premium
The Fly
Unusually active option classes on open October 28th
25d ago
Unusually active option classes on open October 25th
Premium
The Fly
Unusually active option classes on open October 25th
28d ago
ImmunityBio:  ANKTIVA  now covered by more  than  ‘dozen’ insurance plans
PremiumThe FlyImmunityBio: ANKTIVA now covered by more than ‘dozen’ insurance plans
3M ago
ImmunityBio studies ANKTIVA  in  AdHER2DC combo as potential  EC treatment
Premium
The Fly
ImmunityBio studies ANKTIVA in AdHER2DC combo as potential EC treatment
4M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
4M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
5M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
ImmunityBio announces insurance coverage of ANKTIVA across multiple states
Premium
The Fly
ImmunityBio announces insurance coverage of ANKTIVA across multiple states
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100